Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19
pubmed:dateCreated
1992-11-10
pubmed:databankReference
pubmed:abstractText
Dominant expression of T-cell receptor (TCR) alpha or beta chain variable region (V alpha or V beta) gene families has been observed in the T-cell response to some conventional peptide antigens. Current models for the interaction of TCR V region elements with different determinants of a major histocompatibility complex (MHC)-peptide complex, the normal TCR ligand, suggest that the TCR V-J junctional region (CDR3, where J is joining) is the primary contact with a peptide epitope and that other TCR V region segments may interact directly with neighboring MHC determinants. This suggests that V alpha or V beta dominance in a specific response can be MHC-selected. In this case, if related peptides bind to an MHC molecule in a similar orientation, they could select for identical V alpha or V beta dominance even if they are noncrossreactive at the level of T-cell activation. We have screened for this possibility by introducing minimal conservative substitutions in a synthetic peptide, YYEELLKYYEELLK, that is presented to T cells in association with an uncommon A beta E alpha d mixed Ia isotype. We report here that the peptide variant FFEELLKFFEELLK is noncrossreactive with YYEELLKYYEELLK but appears to preserve the same MHC binding motif since T-cell responses are restricted to the same mixed A beta E alpha isotype. Although the two peptides are noncrossreactive in either direction, the same members of the V alpha 4 gene family are dominantly expressed in T cells specific for either peptide. We conclude that the similar topography of the two MHC-peptide complexes gives functional significance to a unique A beta E alpha determinant that selects for V alpha 4 dominance.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-1309938, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-1315417, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-1598575, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-1730914, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-2153168, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-2406610, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-2421164, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-2440339, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-2455603, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-2456856, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-2461560, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-2463672, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-2784852, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-2971535, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-2995827, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-3043226, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-3086873, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-3208747, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-3456487, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-3487085, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-3493320, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-3493439, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-3839904, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-6158548, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-6809821, http://linkedlifedata.com/resource/pubmed/commentcorrection/1384036-7301588
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
89
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
8874-8
pubmed:dateRevised
2010-9-7
pubmed:meshHeading
pubmed-meshheading:1384036-Amino Acid Sequence, pubmed-meshheading:1384036-Animals, pubmed-meshheading:1384036-Antibodies, pubmed-meshheading:1384036-Antigen-Presenting Cells, pubmed-meshheading:1384036-Base Sequence, pubmed-meshheading:1384036-Cloning, Molecular, pubmed-meshheading:1384036-Cross Reactions, pubmed-meshheading:1384036-DNA, pubmed-meshheading:1384036-Gene Library, pubmed-meshheading:1384036-Haplotypes, pubmed-meshheading:1384036-L Cells (Cell Line), pubmed-meshheading:1384036-Lymphocyte Activation, pubmed-meshheading:1384036-Macromolecular Substances, pubmed-meshheading:1384036-Major Histocompatibility Complex, pubmed-meshheading:1384036-Mice, pubmed-meshheading:1384036-Mice, Inbred BALB C, pubmed-meshheading:1384036-Mice, Inbred C3H, pubmed-meshheading:1384036-Molecular Sequence Data, pubmed-meshheading:1384036-Oligodeoxyribonucleotides, pubmed-meshheading:1384036-Peptides, pubmed-meshheading:1384036-Poly A, pubmed-meshheading:1384036-Polymerase Chain Reaction, pubmed-meshheading:1384036-RNA, pubmed-meshheading:1384036-RNA, Messenger, pubmed-meshheading:1384036-Receptors, Antigen, T-Cell, pubmed-meshheading:1384036-T-Lymphocytes, pubmed-meshheading:1384036-Transfection
pubmed:year
1992
pubmed:articleTitle
Major histocompatibility complex determinants select T-cell receptor alpha chain variable region dominance in a peptide-specific response.
pubmed:affiliation
Cancer Center, University of Rochester School of Medicine, NY 14642.
pubmed:publicationType
Journal Article